The Lawrence Law Firm logo
Call To Schedule A Free Consultation

The Lawrence Firm Blog

An updated safety communication has been issued for Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy.

Today, the U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids. In an updated safety communication, originally issued in April 2014, the FDA warns against using laparoscopic power morcellators in the removal of the uterus (hysterectomy) or fibroids (myomectomy) in the vast majority of women.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

You Pay No Fees Unless We Win!

We are happy to offer a free consultation to evaluate your case. If you hire us as your legal counsel, we will represent you on a contingency-fee basis. You will pay no attorneys’ fees unless we recover financial damages.